Zeba N. Singh - Concepedia

Author

Zeba N. Singh

Also Known As

Dr. Zeba N. Singh, Z N Singh, Z Singh, Z. N. SINGH, Z. Singh, ZEBA SINGH, Zeba N Singh, Zeba N. Singh, Zeba Niazi Singh, Zeba Singh

110

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

University of Maryland, Baltimore U-M Rogel Cancer Center Maulana Azad Medical College University of Chicago University of Arkansas for Medical Sciences

About

Zeba N. Singh is an author at University of Maryland, Baltimore specializing in medicine, pathology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	18	970
2	Health Sciences	3	3	122
3	Biochemistry	1	1	28
4	Biostatistics	1	1	106
5	Blood Transplantation	1	1	55

Zeba N. Singh

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Enhancing the Cytotoxic Effects of PARP Inhibitors with DNA Demethylating Agents – A Potential Therapy for Cancer Nidal Muvarak, Khadiza Chowdhury, Limin Xia, Cancer Cell Cytotoxic EffectsA Potential TherapyMedicineParp InhibitorsAnti-cancer Agent	2016	207
Pembrolizumab, pomalidomide, and low-dose dexamethasone for relapsed/refractory multiple myeloma Ashraf Badros, Elizabeth Hyjek, Ning Ma, Blood	2017	194
Castleman disease in the 21st century: an update on diagnosis, assessment, and therapy. Frits van Rhee, Katie Stone, Susann Szmania, PubMed Primary ImmunodeficiencyHiv-negative CdViral PersistenceAutoimmune DiseaseHuman Retrovirus	2010	165
Therapy-Related Myelodysplastic Syndrome Zeba N. Singh, Dezheng Huo, John Anastasi, American Journal of Clinical Pathology Hematological MalignancyWorld Health OrganizationOncologyMixed-phenotype Acute LeukemiaAplastic Anemia	2007	106
Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocols Saad Z. Usmani, Bijay Nair, Pingping Qu, Leukemia Hematological MalignancyOncologyGene-expression ProfilingImmunotherapyMedicine	2012	80
Marizomib for central nervous system‐multiple myeloma Ashraf Badros, Zeba N. Singh, Binod Dhakal, British Journal of Haematology Hematological MalignancyNeuro-oncologySummary MarizomibMedicineNatural Marine Product	2017	64
Major clinical response to nivolumab in relapsed/refractory Hodgkin lymphoma after allogeneic stem cell transplantation Jean A. Yared, Nancy M. Hardy, Zeba N. Singh, Bone Marrow Transplantation Lymphoid NeoplasiaCell TherapyTransplantationMarrow TransplantationRelapsed/refractory Hodgkin Lymphoma	2016	55
A Phase II Study of Anti PD-1 Antibody Pembrolizumab, Pomalidomide and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Ashraf Badros, Mehmet H. Kocoglu, Ning Ma, Blood	2015	55
Asparaginase Erwinia chrysanthemi effectively depletes plasma glutamine in adult patients with relapsed/refractory acute myeloid leukemia Ashkan Emadi, Jennie Y. Law, Erin T. Strovel, Cancer Chemotherapy and Pharmacology Plasma GlutamineMedicineAdult PatientsHematologyAsparaginase Erwinia Chrysanthemi	2017	53
Decreased CD117 expression in hypopigmented mycosis fungoides correlates with hypomelanosis: lessons learned from vitiligo Zeba N. Singh, Maria Tretiakova, Christopher R. Shea, Modern Pathology InflammationCd117 ExpressionAutoimmune DiseaseDisease MechanismImmunodeficiencies	2006	47

Page 1